A new study found that women on aromatase inhibitors or selective estrogen receptor downgraders for ER+ breast cancer have a reduced risk of Alzheimers and other dementias.
Can't conclude that needing these meds is a good thing, but at least it has one upside.
The reduction in risk was greatest for Black women (another rare positive of treatment) and younger women.
(Source: September 6, 2024|Hematology and Oncology, PI Chao Cai)